2025 National Medical Insurance Drug List Released with 114 New Additions, Including 50 Class 1 Innovative Drugs

Deep News

2025/12/07

The 2025 High-Quality Development Conference for Innovative Drugs was held this morning (December 7) in Guangzhou, where the 2025 National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List and the first edition of the Commercial Health Insurance Innovative Drug List were announced.

This marks the eighth adjustment to the National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List since the establishment of the National Healthcare Security Administration. The updated list includes 114 newly added drugs, 50 of which are Class 1 innovative drugs. The inaugural Commercial Health Insurance Innovative Drug List features 19 drugs, covering treatments ranging from CAR-T therapies for cancer to Alzheimer's disease medications that have garnered significant public attention.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1178186595"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1178186595\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1178186595?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-07 09:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1178186595","market":"sg","top_or_hot":-1,"title":"2025 National Medical Insurance Drug List Released with 114 New Additions, Including 50 Class 1 Innovative Drugs","media":"Deep News","content":"<p>The 2025 High-Quality Development Conference for Innovative Drugs was held this morning (December 7) in Guangzhou, where the 2025 National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List and the first edition of the Commercial Health Insurance Innovative Drug List were announced.</p>\n<p>This marks the eighth adjustment to the National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List since the establishment of the National Healthcare Security Administration. The updated list includes 114 newly added drugs, 50 of which are Class 1 innovative drugs. The inaugural Commercial Health Insurance Innovative Drug List features 19 drugs, covering treatments ranging from CAR-T therapies for cancer to Alzheimer's disease medications that have garnered significant public attention.</p>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2025 National Medical Insurance Drug List Released with 114 New Additions, Including 50 Class 1 Innovative Drugs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2025 National Medical Insurance Drug List Released with 114 New Additions, Including 50 Class 1 Innovative Drugs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2025-12-07 09:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The 2025 High-Quality Development Conference for Innovative Drugs was held this morning (December 7) in Guangzhou, where the 2025 National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List and the first edition of the Commercial Health Insurance Innovative Drug List were announced.</p>\n<p>This marks the eighth adjustment to the National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List since the establishment of the National Healthcare Security Administration. The updated list includes 114 newly added drugs, 50 of which are Class 1 innovative drugs. The inaugural Commercial Health Insurance Innovative Drug List features 19 drugs, covering treatments ranging from CAR-T therapies for cancer to Alzheimer's disease medications that have garnered significant public attention.</p>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159992","symbol_name":"创新药","start_time":0,"source_url":"","article_id":"1178186595","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1178186595","pubTimestamp":1765069818,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"The 2025 High-Quality Development Conference for Innovative Drugs was held this morning (December 7) in Guangzhou, where the 2025 National Basic Medical Insurance, Maternity Insurance, and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159992":"创新药","BK1574":"生物医药B类股","06978":"永泰生物-B","BK1161":"生物科技"},"translate_title":"2025年国家医保药品目录发布新增114个1类创新药50个","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1,"06978":1},"content_text":"The 2025 High-Quality Development Conference for Innovative Drugs was held this morning (December 7) in Guangzhou, where the 2025 National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List and the first edition of the Commercial Health Insurance Innovative Drug List were announced.\nThis marks the eighth adjustment to the National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List since the establishment of the National Healthcare Security Administration. The updated list includes 114 newly added drugs, 50 of which are Class 1 innovative drugs. The inaugural Commercial Health Insurance Innovative Drug List features 19 drugs, covering treatments ranging from CAR-T therapies for cancer to Alzheimer's disease medications that have garnered significant public attention.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}